BETH TACCA: Open Payments
NPI 1962603316 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$583 in 44 payments from 7 companies in 2025. Trend: 2023 $312 · 2024 $280 · 2025 $583
Food & beverage: $583
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 11 | $213 |
| Amgen Inc. | 20 | $146 |
| PFIZER INC. | 9 | $146 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| ABBVIE INC. | 1 | $19 |
| Celgene Corporation | 1 | $19 |
| ARGENX US, INC. | 1 | $18 |
Products named: UPLIZNA, NURTEC ODT, Ocrevus, Ocrevus Zunovo, KESIMPTA, UBRELVY, ZEPOSIA, VYVGART HYTRULO.
Industry payments across NY — which companies pay providers there.
